healthcare services

Providing care to patients: hospitals, clinics, home care and care management.

Industry · 9 companies · 4 report it as a revenue line

Show
8-K events
Match any selected event
8-K event types
More events

Only filters 8-Ks. Other selected forms stay visible.

  • CDNA CareDx, Inc

    Sells it, part of Patient And Digital Solutions“Our teams across the country provide staff augmentation services inside transplant centers, helping them operate efficiently.”

    Latest 10-QQ3 FY2026Positive ·

    Naveris adds NavDx oncology testing as lab products exit; accelerating transplant demand and older-test revenue recognition fuel growth.

    • Revenue$139.4MYoY +39.3%
    • Net income$19.3Mvs $1.7M year ago
  • CI Cigna Group

    Sells it 6%, $4.5B a quarter“Intersegment revenue principally reflects pharmacy and care-services transactions between Evernorth and Cigna Healthcare.”

    Latest 10-QQ3 FY2026MixedRestructuring ·

    Rebate-free investment and contract renewals squeeze Evernorth’s pharmacy-benefit earnings; specialty care provides an offset.

    • Revenue$73.7BYoY +5.6%
    • Net income$1.4BYoY −22.8%
  • CVS CVS Health

    Sells it“CVS reported about 9,000 retail locations, more than 1,000 walk-in and primary-care clinics, approximately 87 million PBM plan members and an estimated 37 million people served through health insurance products.”

    Latest 10-QQ3 FY2026Mixed ·

    Planned split separates Aetna and Caremark from CVS Pharmacy as insurance profitability improves and pharmacy pricing pressure persists.

    • Revenue$108.4BYoY +5.4%
    • Net income$2.2Bvs −$4.0B year ago
  • ELV Elevance Health

    Sells it“The company describes Carelon’s strategy as integrating physical, behavioral and social services, applying data and provider enablement, and expanding value-based care, including home and virtual care for complex populations.”

    Latest 8-KGuidance reaffirmed ·

    FY2026 outlook reaffirmed for investor meetings: EPS of at least $22.00 diluted and $29.00 adjusted.

  • HCA HCA Healthcare

    Sells it 96%, $19.0B a quarter“HCA operated 182 U.S. hospitals across its geographic groups and seven hospitals in England, along with 117 freestanding surgery centers and 30 freestanding endoscopy centers.”

    Latest 8-KDebt financing ·

    Completed a $6.5B senior notes offering through HCA Inc., backed by HCA Healthcare’s senior unsecured guarantee.

  • UNH UnitedHealth Group

    Sells it 8%, $8.6B a quarter“A strategic review begun in Q4 2025 focused on advancing and scaling core operations, including Optum Health’s value-based-care business.”

    Latest 8-KLeadership change ·

    Former Children’s Hospital of Philadelphia CEO Madeline Bell joins the board, bringing patient-care and hospital leadership experience.

  • VRHI Veri MedTech Holdings, Inc.

    Sells it“Veriheal Inc. (“Veriheal”) was founded in the state of Delaware on November 17, 2017, by Joshua Green and Samuel Adetunji to provide concierge services to patients seeking prescription cards for medical marijuana.”

    Latest S-1/Aamended IPO prospectusNegativeBankruptcy / going concernAccounting issueControlled company ·

    Connects patients with physicians for medical-cannabis certifications; FY2025 revenue fell 34.9% Y/Y as state restrictions hit consultations

  • WM Waste Management, Inc

    Sells it 10%, $651.0M a quarter“Following its Stericycle acquisition, Healthcare Solutions is shifting from integration toward scalable growth.”

    Latest 10-QQ3 FY2026Positive ·

    Pricing carries collection growth as commercial volumes soften; lower recycling impairments drive much of the profit rebound.

    • Revenue$6.8BYoY +6.3%
    • Net income$820.0MYoY +36.0%
  • WMT Walmart

    Sells it, part of Walmart US, Walmart International, Sam's Club US“Health and wellness includes pharmacy, over-the-counter drugs and other medical products, and optical services.”

    Latest 8-KPositiveEarningsGuidance raised ·

    Better Walmart U.S. merchandise mix and higher membership income lift profit; FY2027 adjusted EPS outlook raised to $2.84–$2.89

Feedback